# A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)

> **NCT00559182** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 47 (actual)

## Conditions studied

- Advanced Cancer

## Interventions

- **DRUG:** Comparator: MK-8033
- **DRUG:** Comparator: MK-8033 +/- omeprazole

## Key facts

- **NCT ID:** NCT00559182
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-05
- **Primary completion:** 2010-06-10
- **Final completion:** 2010-07-09
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2022-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559182, "A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00559182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*